baber/WOPTO huggingface dataset:
Patent JP-3748349-B2 (JP)
IPC: B41N1/08
Filed: 1999-11-11
Granted: 2006-02-22
Abstract: A lithographic printing plate precursor which comprises a metal support having provided thereon a heat-insulating layer, a metal layer having a hydrophilic surface, and a lipophilic layer which is abraded by heating or whose solubility to alkali is transformed by heating, in this order from the support.
Patent JP-2874922-B2 (JP)
IPC: C07D213/78
Filed: 1989-12-13
Granted: 1999-03-24
Abstract: Pyridine-3-percarboxylic acid monopersulfate of formula: <CHEM> the process for its preparation and the use thereof as bleaching agent are described.
Patent JP-2611736-B2 (JP)
IPC: H04W88/02
Filed: 1993-12-27
Granted: 1997-05-21
Abstract: PURPOSE:To obtain the portable telephone terminal having an addition and distribution function of voice signals. CONSTITUTION:A conversion circuit 2 sends/receives an electric signal with an antenna 1 and sends/receives a channel signal with a channel multiplexer/ demultiplexer circuit 3. The channel multiplexer/demultiplexer circuit 3 demultiplexes the channel signal into a control channel and individual voice signal channel and multiplexes the control channel and the individual voice signal channels into one channel signal. A control circuit 4 applies termination control to the control channel. An adder circuit 5 adds voice signals superimposed on respective channels demultiplexed by the channel multiplexer/ demultiplexer circuit 3. A voice amplifier circuit 6 converts the voice signal added by the adder circuit into a prescribed listening sound pressure level and converts a voice uttered by a subscriber into a prescribed electric signal level. A voice distribution circuit 7 distributes voice signals outputted from the voice amplifier circuit into each channel.
Patent JP-2591860-B2 (JP)
IPC: H04W92/00
Filed: 1990-11-29
Granted: 1997-03-19
Abstract: PURPOSE:To prevent provision of a interfering radio wave to another circumferential station by using a special signal included in a signal incoming from a MODEM instead when a special signal included in a transmission signal from its own transmitter to be compared with a synchronization reference signal is not decoded so as to implement start stop control of the transmitter. CONSTITUTION:A peripheral station 2 uses an RF receiver 9 to receive and demodulate its own peripheral station radio wave 7 and a reference station radio wave 6 from a reception antenna 5. Moreover, a time difference between a special signal (1) included in the demodulation signal of its own peripheral station used as a reference and a special signal (2) included in a signal of a reference station, measures the phase quantity equivalently and the result is corrected by a variable delay section 8 to synchronize the phase of a transmission signal of each peripheral station. In this case, since the frequency of a received radio wave is the same, the transmitter 34 is controlled by using a transmitter control signal 17 based on the special signal (1) included in the signal of its own peripheral station. On the other hand, the transmitter 3 is controlled by using a transmitter control signal 18 based on the special signal (1) decoded by a code decoding section 11 connecting to an output of the variable delay section 8. When a code decoding section 10 cannot decode the special signal (1), the control section 14 uses the selection signal to select the transmitter control signal 18.
Patent JP-2957709-B2 (JP)
IPC: C08F220/18
Filed: 1990-12-21
Granted: 1999-10-06
Abstract: Disclosed are graft copolymers of polyolefins and a method of preparing said graft copolymers. The method comprises irradiating a mass of olefin polymer particles and thereafter treating the mass of particles with a vinyl monomer in liquid form. A nonoxidizing environment is maintained throughout the process while free radicals produced in the olefin polymer by the irradiation are present, thereby preventing degradation of the polymer. In a final step, residual free radicals are deactivated, and any unreacted monomer is removed. <IMAGE>
Patent JP-H0536050-B2 (JP)
IPC: A47J19/02
Filed: 1988-11-21
Abstract: A press particularly useful as a garlic press that includes a two-piece bowl having a plurality of holes through one surface thereof (e.g. the bottom surface). The bowl is preferably hinged along one side wall so that the bowl can be opened into two separate portions connected at the hinge. Each portion of the bowl includes a plurality of grooves on the contacting edges of the two portions. An arm is connected on the side of each bowl opposite the hinge, and when the two arms are brought together, the bottom surface of the bowl is unified with the grooves forming the openings in the bottom surface. A plunger depressed over the garlic minces the garlic or other pressable article placed in the bowl. Then the bowl may be opened about the hinge so as to permit the sidwall of the openings to be exposed for easy cleaning.
Patent JP-2622535-B2 (JP)
IPC: B05C11/10
Filed: 1988-12-09
Granted: 1997-06-18
Abstract: The invention relates to the field of hot melt dispensing, and in particular, dispensers capable of: unloading a drum of solid hot melt into a supply reservoir; liquifying the hot melt to a dispensable state; and dispensing the liquified hot melt through a pumping arrangement. The invention solves this problem by providing a melting grid (35a) above the heated supply reservoir (35) to catch the solid melt after it is deposited from drum (22) in heated hopper (21).
Patent JP-2683557-B2 (JP)
IPC: C07D239/62
Filed: 1987-12-23
Granted: 1997-12-03
Abstract: Disclosed are substituted derivatives of 5-diazobarbituric acid selected from those having the formulas:   <IMAGE>    <IMAGE> wherein R1 and R2 are substituents selected from the group consisting of C3 to C12 alkyl, cyclohexyl, benzyl and C2 to C6 aralkyl groups, wherein R3 and R4 are substituents selected from the group consisting of C1 to C12 alkyl, cyclohexyl, benzyl or other C2 to C6 aralkyl groups and R5 is selected from the group consisting of  alpha , omega -disubstituted C2 to C12 alkyl, methylene dicyclohexyl, or C1 to C6 dialkylphenylene. These compounds provide DUV response with an absorption maximum near 260 nm. The substituents are chosen to be nonabsorbing alkyl groups that allow efficient photobleaching of the sensitizer during exposure. The sensitizers of the present invention are designed to function in the DUV region and are useful in the manufacture of semi-conductor devices.
Patent JP-3127998-B2 (JP)
IPC: A61P3/06
Filed: 1991-11-15
Granted: 2001-01-29
Abstract: A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.
Patent JP-2811369-B2 (JP)
IPC: G10L19/02
Filed: 1990-01-29
Granted: 1998-10-15
Abstract: An encoder applies a digital filterbank such as a transform or subband filterbank to an input signal to generate frequency subband information, encodes the resultant subband information using adaptive bit allocation to generate fixed-length values represented by fixed numbers of bits and variable-length values represented by variable numbers of bits, and formats the subband information into an encoded signal in which the fixed-length values are assembled into preestablished positions within the encoded signal. In response to an encoded signal including subband information represented by fixed-length values and variable-length values, a decoder extracts fixed-length values represented by fixed numbers of bits from preestablished positions within the encoded signal, extracts variable-length values represented by variable numbers of bits, wherein the variable numbers of bits are established in response to fixed-length values, and generates an output signal by applying an inverse filterbank to the extracted subband information. <IMAGE>
Patent JP-2849665-B2 (JP)
IPC: G01N23/223
Filed: 1989-05-12
Granted: 1999-01-20
Abstract: PCT No. PCT/GB89/00518 Sec. 371 Date Nov. 13, 1990 Sec. 102(e) Date Nov. 13, 1990 PCT Filed May 12, 1989 PCT Pub. No. WO89/11095 PCT Pub. Date Nov. 16, 1989.A method and apparatus for measuring simultaneously the thickness and the composition of a coating on a metal substrate. A first beam of radiation that produces a primary beam of photons is directed substantially perpendicularly to the surface of the coating. A first detector is positioned substantially perpendicularly to the surface of the coating to receive a first fluoresced beam. The photons having a first energy level representing a higher concentration element of the coating are selected. A first electrical signal is provided that is a function of the intensity of the photons having the first energy level. A second beam of radiation producing a second primary beam of photons is directed at an acute angle to the surface of the coating. A second detector is positioned substantially perpendicularly to the surface of the coating to receive a second fluoresced beam. The photons having a second energy level representing a lower concentration element of the coating are selected. A second electrical signal is provided that is a function of the intensity of the photons having the second energy level. From the first and second electrical signals, the relative composition of the elements of the coating and the thickness of the coating are simultaneously calculated.
Patent JP-H0450052-B2 (JP)
IPC: C23G1/36
Filed: 1987-10-14
Abstract: We have discovered an improved, energy efficient method for recovering and regenerating acid from a solution comprising acid and salt. The process comprises of the steps of supplying a solution comprising salt and a first concentration of acid to a first compartment (D) of an electrodialysis apparatus (2) comprising a first compartment and a second compartment (C), supplying a liquid comprising water to the second compartment, applying a direct current to the electrodialysis apparent to form, in the first compartment, a first product comprising salt and a second concentration of acid, the second concentration of acid being less than the first concentration of acid, and, in the second compartment, a second product comprising water and enriched in acid by a proportionite amount, recovering the first product, recovering the second product, recovering acid from the first product using electrodialytic water splitting (11) to convert at least a portion of the salt to a third product comprising acid, and recovering the third product. The process has particular utility for the recovery and regeneration of mixed acids from spent pickle liquors containing free nitric acid and salts of an anion other than nitrate anion.
Patent JP-3143749-B2 (JP)
IPC: A61P3/04
Filed: 1994-09-01
Granted: 2001-03-07
Abstract: A method for promoting weight control by treating a subject with a therapeutic amount of one of the  DELTA 5-androstenes listed below to stimulate weight control without affecting appetite or inducing the synthesis of sex hormones.  DELTA 5-Androstenes providing the desired biological activities include: (1)  DELTA 5-Androstene-3 beta ,7 alpha -diol-17-one, (2)  DELTA 5-Androstene-3 beta -ol-7,17-dione, (3)  DELTA 5-Androstene-3 beta ,7 alpha ,17 beta -triol, (4)  DELTA 5-Androstene-3 beta ,17 beta -diol-7-one, (5)  DELTA 5-Androstene-3 beta -acetoxy-7,16,17-trione, (6)  DELTA 5-Androstene-3 beta ,16 alpha -dihydroxy-7,17-dione, (7)  DELTA 5-Androstene-3 beta -propionoxy-16 beta -acetoxy-7,17-dione, (8)  DELTA 5-Androstene-3 beta ,7 alpha ,17 beta -triol-16-one, (9)  DELTA 5-Androstene-3 beta ,17 beta -diol-7,16-dione, (10)  DELTA 5-Androstene-3 beta ,16 alpha ,17 beta -triol-7-one and derivatives thereof wherein one or more of the hydroxyl or keto substituents is a group convertible thereto by hydrolysis.
Patent JP-2901083-B2 (JP)
IPC: A63B69/26
Filed: 1989-08-25
Granted: 1999-06-02
Abstract: An exercising device can be used for fun and for aerobic exercise. A rebound board is placed against the pelvic area of a person, and a ball is tethered to the board by a stretchable tether. The person can somewhat bounce, bending and straightening the knees, with consequent movement of the hips causing the ball to bounce rhythmically on the rebound board. More or less energetic movement of the hips renders the exercise more or less strenuous, and weights can be held in the hands to increase the stress.
Patent JP-2902484-B2 (JP)
IPC: A61K31/443
Filed: 1995-09-29
Granted: 1999-06-07
Abstract: PCT No. PCT/EP95/03884 Sec. 371 Date Apr. 3, 1997 Sec. 102(e) Date Apr. 3, 1997 PCT Filed Sep. 29, 1995 PCT Pub. No. WO96/11195 PCT Pub. Date Apr. 18, 1996Compounds of formula (I), pharmaceutically acceptable salts thereof, and pharmaceutically acceptable solvates (including hydrates) of either entity, wherein R1 is (a) R2 is R3R4C(OH)A; V is C=O or CH2; W is O or NR5; R3 and R4 are each independently selected from H and C1-C4 alkyl; or, together with the carbon atom to which they are attached, form a 4- or 5-membered carbocyclic ring; R5 is H, benzyl, C1-C5 alkanoyl or SO2(C1-C4)alkyl; A is C2-C3 alkylene; m is 0 or 1; and n is 0 or 1; with the provisos that when n is 1 and V is C=O then W is NH, and when n is 1 and V is CH2 then W is O; are selective 5-HT1-like agonists useful in the treatment of, inter alia, migraine, cluster headache, chronic paroxysmal hemicrania and headache associated with vascular disorders.    <IMAGE>  (I)   <IMAGE>  (a)
Patent JP-3258324-B2 (JP)
IPC: C07D319/12
Filed: 1993-01-22
Granted: 2002-02-18
Abstract: A process for preparing a polylactide; the process including: providing a crude lactide mixture including lactide comprising meso-lactide and at least one of L-lactide and D-lactide; said process being characterized by steps of:   (a) purifying the crude lactide mixture by distillation in a distillation system into at least two distilled fractions comprising:       (i) a low-boiling fraction; and (ii) an intermediate boiling fraction including purified polymer grade lactide, without a step of solvent extraction of the crude lactide mixture or recrystallization of the crude lactide mixture; and   (b) reacting the purified polymer grade lactide to form polylactide.
Patent JP-4073961-B2 (JP)
IPC: C07D405/12
Filed: 1997-10-01
Granted: 2008-04-09
Abstract: The present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of PDGF receptor to hinder abnormal cell growth and cell wandering and thus are useful for the prevention or treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis. The compounds are represented by general formula (I): <CHEM>       wherein V represents an oxygen atom or a sulfur atom; W represents 1,4-piperazinediyl or 1,4-homopiperazinediyl in which carbons on the ring may be substituted by unsubstituted alkyl groups;     X represents a nitrogen atom or C-R<9>;   Y represents a nitrogen atom or C-R<8>; Z represents a nitrogen atom or C-R<7> (provided that at least one of X, Y and Z represents a nitrogen atom); R<1> represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alicyclic alkyl group, etc.; R<2> represents a substituted alkyl group, a substituted or unsubstituted alicyclic alkyl group, etc.; R<3>, R<4>, R<5> and R<6>, which may be the same or different, each represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a nitro group, a cyano group, - OR<12>, -NR<15>R<16>, etc.;   R<7> represents a halogen atom, etc.;   R<8> has the same significance as R<7>, and R<9> represents a hydrogen atom or -COR<41>.
Patent JP-2572715-B2 (JP)
IPC: A61P9/06
Filed: 1993-04-30
Granted: 1997-01-16
Abstract: PCT No. PCT/US93/03921 Sec. 371 Date May 3, 1995 Sec. 102(e) Date May 3, 1995 PCT Filed Apr. 30, 1993 PCT Pub. No. WO93/23428 PCT Pub. Date Nov. 25, 1993Polypeptides isolated from the venom of the Filistata hibernalis spider block calcium channels in cells of various organisms and are useful in blocking said calcium channels in cells, per se, in the treatment of calcium channel-mediated diseases and conditions and in the control of invertebrate pests.
Patent JP-3736807-B2 (JP)
IPC: H04B/
Filed: 1995-12-22
Granted: 2006-01-18
Abstract: The present invention discloses a communication station for communicating with a second station in a cellular-communication network using spread spectrum modulation wherein the second station transmits power commands to the communication station based on a received power level from the communication station, the communication station comprising: a transmitter having an adjustable transmitter power level for transmitting spread-spectrum signals; means for sequentially receiving power commands from a second station with which communication is being conducted; means for comparing a sequence of at least two of the received power commands to determine if the received commands in the sequence match; and means for adjusting the transmitter power level at a same rate as the reception of the power commands; wherein if the command sequence matches the transmitter power level is adjusted by a different amount than if the command sequence does not match. A method for adjusting a transmitter power level is also disclosed.
Patent JP-3756193-B2 (JP)
IPC: A61K45/00
Filed: 1996-12-17
Granted: 2006-03-15
Abstract: PCT No. PCT/SE96/01677 Sec. 371 Date Sep. 21, 1998 Sec. 102(e) Date Sep. 21, 1998 PCT Filed Dec. 17, 1996 PCT Pub. No. WO97/22339 PCT Pub. Date Jun. 26, 1997This invention relates to a method for treating snoring, sleep apnea and other form of sleep-disordered breathing, which comprises administration of a therapeutically effective dose of an acetyl choline esterase inhibitor (CEI) such as pyridostigmine or a pharmaceutically acceptable salt thereof.
Patent JP-3733141-B2 (JP)
IPC: H04M1/24
Filed: 1995-03-29
Granted: 2006-01-11
Abstract: PCT No. PCT/GB95/00716 Sec. 371 Date Sep. 25, 1996 Sec. 102(e) Date Sep. 25, 1996 PCT Filed Mar. 29, 1995 PCT Pub. No. WO95/26604 PCT Pub. Date Oct. 5, 1995The present invention relates to an adaptive telephone interface for use in a telephone apparatus comprising a telephone terminal including signal amplifier means, and audio/input device. The telephone interface is disposable between the terminal and the audio/input device, and comprises a processor for generating a test signal and sending this to the terminal at a plurality of different amplitudes. The processor is further formed and arranged for monitoring signals returned from the terminal by means of sidetone coupling, so as to identify the test signal amplitude at which clipping of at least part of the test signal occurs, and consequentially adjusting the amplification by the interface of a signal received from the audio input device, before sending it on to the terminal so as to avoid substantially clipping thereof by the terminal signal amplifier means in use of the telephone apparatus.
Patent JP-3342019-B2 (JP)
IPC: A61M16/04
Filed: 1997-12-05
Granted: 2002-11-05
Abstract: An artificial respiration device for giving artificial respiration to a human being or mammal, includes a tube designed to pass through the mouth and the pharynx towards the entrance of the trachea until beyond the vocal chords. The far end of the tube for passing towards the trachea opens out into a flexible hose having a greater diameter than the tube, the hose is made of a material or materials with a certain memory. A pulling force exerted on the end of the hose makes the hose constrict, in such a way, that after the hose has been constricted, memory action causes it to assume substantially its original shape after the removal of the pulling force.
Patent JP-4579349-B2 (JP)
IPC: A61K31/34
Filed: 1996-03-14
Granted: 2010-11-10
Abstract: The invention describes the regulation of cervical dilatation and extensibility by the use of nitric oxide donors and/or substrates or nitric oxide inhibitors. There can be used either(a) at least one nitric oxide donor and/or substrate for manufacture of a medicament to be administered locally intracervically or intravaginally for induction of cervical ripening or(b) at least one nitric oxide inhibitor for manufacture of a medicament to be administered locally intracervically or intravaginally for treatment of cercvical insufficiency or preterm labor.
Patent JP-4108122-B2 (JP)
IPC: C12R1/19
Filed: 1996-05-14
Granted: 2008-06-25
Abstract: A method for expressing a heterologous protein in a prokaryotic host cell, comprising the steps of: (a) providing a DNA vector having: (1) a control region operatively linked to a first genetic element encoding a carrier protein capable of expression in the host cell, and (2) a second genetic element encoding the heterologous protein, the second element being embedded within the first element such that the first and second elements are contiguous and in the same reading frame; (b) transforming the host cell with the DNA vector; and (c) expressing a fusion protein of the heterologous protein and the carrier protein, wherein the heterologous protein is joined at its N-terminus to a first domain of the carrier protein and at its C-terminus to a second domain of the carrier protein, and also a method for confirming intact expression of heterologous proteins, as well as fusion proteins, DNA constructs, plasmid vectors and transformed host cells relating to the above methods.
Patent JP-3172539-B2 (JP)
IPC: B29C48/90
Filed: 1996-05-21
Granted: 2001-06-04
Abstract: The invention relates to a transparent, amorphous sheet having a thickness in the range from 1 to 20 mm which contains, as principal constituent, a crystallizable thermoplastic, where the surface gloss, measured in accordance with DIN 67530 (measurement angle 20°), is greater than 130, the light transmission, measured in accordance with ASTM D 1003, is greater than 84%, and the haze of the sheet, measured in accordance with ASTM D 1003, is less than 15%, to a process for the production of the sheet, and to the use of the sheet.
Patent ES-2199651-B2 (ES)
Title: Jaulas para el engorde en cautividad de la rana verde iberica (rana perezi) en su fase inicial.
Inventor: ALVAREZ NOGAL RAFAEL
IPC: A01K63/00
Filed: 2001-09-18
Granted: 2005-06-16
Abstract: Se refiere a una jaula de engorde de la rana verde ibérica (Rana perezi) criada en cautividad, durante la fase inicial de dicho engorde. La jaula (fig. 1), construida principalmente con materiales sintéticos, presenta dos zonas diferenciadas una parte seca compuesta de comederos y refugios, y una parte húmeda con una piscina con dos alturas; y presenta entrada y salida de agua.
Patent ES-2537834-B2 (ES)
Title: Sistema y método de sincronización temporal entre múltiples sistemas
Inventor: BASULTO JORGE A
IPC: G06F11/00
Filed: 2014-09-09
Granted: 2016-02-16
Abstract: Sistemas y métodos para la sincronización temporal entre múltiples sistemas de una máquina minera. El sistema incluye un controlador lógico programable (PLC) para controlar la máquina minera y para transmitir una hora con el fin de sincronizar los sistemas informáticos de la máquina. El PLC incluye un reloj de sistema que se programa para funcionar en una hora local. Un grupo de baterías está conectado al PLC para permitir al reloj de sistema funcionar de forma continua, incluso cuando la máquina está apagada. Los subsistemas informáticos solicitan y reciben actualizaciones temporales desde el PLC. Se determina una hora local en cada subsistema informático basándose en la actualización temporal recibida desde el PLC. Cada subsistema informático incluye un parámetro de uso horario ajustado en la Hora Universal Coordinada (UTC), y un parámetro de Hora para Ahorro por Luz Diurna (DST), que está inhabilitado. De acuerdo con ello, la hora local de cada subsistema informático se ajusta en el valor de actualización temporal recibido desde el PLC.